Phạm, T.L. et al. 2024. RESULT OF PEMBROLIZUMAB PLUS CHEMOTHERAPY IN THE FIRST-LINE THERAPY FOR DISTANT METASTATIC NON-SMALL-CELL LUNG CANCER WITH PD-L1 ≥1%, EGFR(-), ALK(-) AND ROS1(-). Journal of 175 Practical Medicine and Pharmacy. 37 (Mar. 2024), 13. DOI:https://doi.org/10.59354/ydth175.2024.240.